Artificial heart at the meeting of the American Society for Artificial Internal Organs held in Atlantic City in March 1961. At that meeting, Liotta described the implantation of three types of orthotopic (inside the pericardial sac) TAHs in dogs, each of which used a different source of external energy: an implantable electric motor, an implantable rotating pump with an external electric motor, and a pneumatic pump. In 1964, the National Institutes of Health started the Artificial Heart Program, with the goal of putting a man-made heart into a human by the end of the decade. The purpose of the program was to
Artificial intelligence in healthcare Clinic, Memorial Sloan Kettering Cancer Center, Massachusetts General Hospital, and National Health Service, have developed AI algorithms for their departments. Large technology companies such as IBM and Google, and startups such as Welltok and Ayasdi, have also developed AI algorithms for healthcare. Research in the 1960s and 1970s produced the first problem-solving program, or expert system, known as Dendral. While it was designed for applications in organic chemistry, it provided the basis for the subsequent system MYCIN, considered one of the most significant early uses of artificial intelligence in medicine. MYCIN and other systems such as INTERNIST-1 and CASNET did